In contrast, in hormone-refractory prostate cancer, Sortilin is weakly expressed and plays a more protective role by promoting the endocytosis and lysosomal targeting of progranulin, an autocrine growth factor that favors the migration, proliferation and clonogenicity of prostate tumor cells (36). Here, GRN is linked to prostate neoplasm.